Skip to main content

Bicycle Therapeutics PLC

BCYC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001761612

No open-market purchases or sales by Bicycle Therapeutics PLC insiders were filed in the last 90 days; 103 institutions reported holding it in 13F filings for Q2 2026, worth $157.9M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Bicycle Therapeutics PLC changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of BCYC: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders3954+15
Shares11.4M12.4M+991.7K (+8.7%)
Value$341.2M$376.9M+$35.7M (+10.5%)

New holders (18)

Institutions that held Bicycle Therapeutics PLC at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to BCYC in Q2 2021
InstitutionSharesValue% of portfolio
Dorsey Wright & Associates125,675$3.81M0.81%
Envestnet Asset Management Inc42,665$1.29M0.00%
Stifel Financial Corp42,138$1.28M0.00%
Millennium Management LLC20,363$618.0K0.00%
Vestmark Advisory Solutions, Inc.10,055$305.0K0.02%
Wrapmanager Inc9,666$293.0K0.08%
TownSquare Capital, LLC7,828$250.0K0.01%
Legal & General Group Plc8,031$244.0K0.00%
Virtus ETF Advisers LLC7,509$228.0K0.09%
Geode Capital Management, LLC7,479$227.0K0.00%
Personal Cfo Solutions, LLC7,285$221.0K0.05%
Truist Financial Corp7,129$217.0K0.00%
WealthShield Partners, LLC879$27.0K0.00%
Lindbrook Capital, LLC500$15.0K0.00%
Castleview Partners, LLC253$8.00K0.00%
American Portfolios Advisors114$3.46K0.00%
Advisory Services Network, LLC100$3.00K0.00%
Deutsche Bank AG1$00.00%

Sold out (3)

Institutions that held Bicycle Therapeutics PLC at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of BCYC in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
Marshall Wace North America L.P.91,640$2.74M
California Public Employees Retirement System18,300$547.0K
Eudaimonia Partners, LLC515$15.0K